The author and journal apologise for an error in the above paper, which appeared in volume 1 part 2, pages 95--102. The error relates to some of the values in [Table 1](#tbl1){ref-type="table"}. The author\'s dataset for HbA1c in 2009 were in different units to data from 2002, which made the calculation of mean HbAb1c incorrect. The mean HbA1c (%) in 2009 should read 7.6 (1.5) and the mean HbA1c (mmol/mol) should read 60.

###### 

Cardiovascular risk factor and medication profiles of study population at baseline and in 2009. Values expressed as arithmetic mean ([s.d.]{.smallcaps}).

                                                           **Measurements in 2002**   **Measurements in 2009**
  -------------------------------------------------------- -------------------------- --------------------------
  HbA1c (%)                                                8.0 (1.6)                  7.6 (1.5)
  HbA1c (mmol/mol)                                         64                         60
  eGFR (ml/min per 1.73 m^2^)                              72 (18)                    70 (27)
  BMI (kg/m^2^)                                            31.8 (7.6)                 31.0 (6.9)
  BMI \>30 kg/m^2^ (%)                                     55                         49.2
  Systolic BP (mmHg)                                       138 (18)                   134 (20)
  Diastolic BP (mmHg)                                      75 (11)                    71 (10)
  Total cholesterol (mmol/l)                               4.6 (0.9)                  3.9 (0.9)
  HDL cholesterol (mmol/l)                                 1.2 (0.3)                  1.3 (0.4)
  Percentage of subjects on ACE inhibitors or ARBs         43.5% (in 2002)            67.8% (2002--2009)
  Percentage of subjects on anti-hypertensive medication   54% (in 2002)              79.6% (2002--2009)
  Percentage of subjects on metformin                      58.5% (in 2002)            80.3% (2002--2009)
  Percentage of subjects on sulphonylureas                 36% (in 2002)              61% (2002--2009)
  Percentage of subjects on insulin                        29.5% (in 2002)            43.3% (2002--2009)
  Percentage of subjects on statins                        59% (in 2002)              85.5% (2002--2009)

eGFR, estimated glomerular filtration rate by the modification of diet in renal disease equation; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; ACE, angiotensin-converting enzyme; ARB, angiotensin-2 receptor blocker.
